| Fund2 | noticible event | ||
|---|---|---|---|
| 2017 September | BilliontoOne | Prenatal testing for every expecting mother | Raises Series A |
| 2017 October | Locus Biosciences | CRISPR-Cas3 Biotech Drug Development | Announces 818M deal |
| 2018 February | Orphidia | Universal Platform For All Blood Tests | |
| 2018 March | Mycroft AI | Alternative to Amazon Alexa. Opensource | |
| 2018 October | Wisp | D2C for preventing Herpes | |
| 2019 January | LawThis | Lawyers marketplace | |
| 2019 January | EvoEstate | Real Estate investment platform | |
| 2019 March | Bikeep | Protecting bikes from thieves. Saas for bike sharing | |
| 2019 June | NorthOne | Online bank for Business in Canada (USA) | |
| NOW | Your startup | Need cash or web development services? | Pitch me! |
| Fund 1 | 2014 - 2016 | |
|---|---|---|
| 2014 | Wefunder | exited with 7% roi |
| 2014 | BoxC | |
| 2014 | Soothe (seed round) | Skipped Series A. Participated in series B. Skipped Series C |
| 2014 | Enevo | Skipped next round |
| 2015 | Italist | |
| 2015 | Molekule (pre-seed) | Raised multiple follow up rounds. (Seed, Series A, B) Did not invest bc did not have pro-rata rights |
| 2015 | Skyfront | |
| 2016 | Revolut (Series A) | Received 20x cash offer. Still holding position |
| 2016 | Gone | Bankrupt |
2017 August. Revolut. Attracted 66M investment at 420M valuation. I got a cash offer to sell my shares at x5. Decided to keep, because i believe Revolut can be 4-40 billion company. With exit from Wefunder and current Revolut and Soothe valuations i am close to break-even.
2018 Summer. Revolut is a unicorn valued at 1.7B. I get 20x cash offer and refuse because i think this can go up 20x more. It can beat Paypal (90B) valuation. Although there is big competition – Cash app from Square is the first one that comes to mind and is run by great founder.
Technically all my first startup fund is covered only by Revolut. Also my other companies Molekule, Enevo, Italist and Soothe have great paper returns.
My mistake from Fund1 is that i put different amounts to different projects. Another mistake i did not continue on follow up rounds of Enevo and Soothe. (although i participated in 3d rounds). I knew in theoretically that I have to follow on, but I did not behave like this, because I was following the lead investors (super angels make mistakes as well 🙂 ).
I am trying different investment vehicles / asset classes to find out where can i have the edge. Investing in startups was one of them 2014-2016. I have made 9 investments in startups via Angel List, Crowdcube, Seedrs (UK) and Wefunder.
Reading list: